Molbio Diagnostics down 2% even after Q2 profit reported
Molbio Diagnostics shares fell 2% after reporting consolidated profit of ₹58.7 crore in Q2 versus a ₹23.7 crore loss in the year-ago period.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.